van der Hoeven, Nina W <br/><br/>
Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST-Segment-Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long-Term Follow-Up of the REDUCE-MVI Trial.  [electronic resource] 

 -  Journal of the American Heart Association  03 2020 
 - e014411 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.119.014411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Drug Administration Schedule<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Platelet Activation--drug effects<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Function Tests<br/>Prasugrel Hydrochloride--therapeutic use<br/>ST Elevation Myocardial Infarction--drug therapy<br/>Spain<br/>Ticagrelor--therapeutic use<br/>Time Factors<br/>Treatment Outcome